Introduction: Neurointerventional medicine refers to a clinical medicine science that uses intravascular catheter operation technology to diagnose and treat lesions involving blood vessels of the human nervous system with the support of the DSA system, so as to achieve the treatment purposes of embolization, dissolution, dilation, shaping and anti-tumor.
Development prospects
According to the data of the "China Stroke Prevention and Treatment Report (2019)", the number of stroke people in my country with 40 years old and above has reached 13.18 million, with 2.4 million new stroke patients every year and showing a trend of younger age. As we all know, cerebrovascular disease is one of the most important diseases that cause death to Chinese people. With the improvement of national economic level and the aging of the population, there are millions of new patients in my country every year, which puts forward higher development requirements for neural intervention technology .
Treatment objects
mainly includes vascular abnormalities in the brain, meninges, maxillofacial, neck, eyes, ears, nose and throat, spine, and spinal cord.
Treatment technology
is divided into endovascular embolization, intravascular drug perfusion and angioplasty. The pathways or treatment subjects of the above treatment process are related arteries and drainage veins.
Technical advantages
avoids tissue trauma caused by craniotomy surgery, and its adaptability is wide, simple operation, small trauma, accurate efficacy, and few complications. It has the advantages of other diagnostic and treatment methods that are incomparable to it and is an important part of micro-invasion neurosurgery.
Clinical application
Neurointerventional medicine has gradually developed and grown from nothing to something in just a few decades, and has occupied an increasingly important position in the field of neurosurgery, especially in the diagnosis and treatment of cerebrovascular diseases.
1st century, with the continuous deepening of research on the pathogenesis of cerebrovascular diseases, various catheter technologies and embolization materials have been continuously developed and improved. At the same time, multi-mode CT, high-score nuclear magnetic field and dual-C-arm DSA have been launched one after another, and the introduction of more disease evaluation methods (OCT, FFR, etc.) has made neural intervention more realistic, more reliable and safer, which undoubtedly has become the "potential" for the development of neurointerventional medicine.
China's neurointervention has developed in the past twenty years. Grassroots clinicians can obtain standardized training synchronized with the world. Patients in remote areas can receive high-level neurointervention diagnosis and treatment services.
In short, neurointerventional medicine has improved the level of diagnosis, treatment and clinical research in cerebrovascular diseases, thus promoting the development of the entire neurosurgery.
department 8 department recommendation
Neurosurgery Department of Changzhi Second People's Hospital is a municipal key clinical discipline in Changzhi City and a municipal key clinical specialty in Changzhi City. now has 45 beds, 15 medical staff, 3 deputy chief physicians, 4 attending physicians, 1 deputy chief nurse, 23 chief nurse html, and 4 nurses. The technical strength is becoming increasingly strong, and its popularity in the region has increased significantly. The Department of Neurosurgery Department designated a "collaborative hospital" to be affiliated with the Department of the Minimally Invasive Hematoma Elimination Promotion Group of the National Health Commission; it is a member unit of the China Doctors Alliance for Consciousness; it is the first batch of demonstration units for the joint construction of spinal and spinal cord surgery of the Chinese Medical Association; it is the Changzhi Branch of the Shanxi Spinal and Spine Minimally Invasive Center; it is the Provincial Medical Expert Workstation of the 136 Xingyi Engineering Neurosurgery; it is the Sanbo Brain Hospital of Capital Medical University Medical Alliance Core Cooperative Hospital; it is the core member unit of the National Clinical Key Specialty Sanbo Neurosurgery Alliance.
(Source: Changzhi Second People's Hospital)
(Editor: Zhang Wenwei)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-